Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
– Rademikibart significantly improved lung function and asthma control in patients with…
Eternal’s Initiatives to Support Delivery Partners during the Heatwave
NEW DELHI, June 12, 2025 /PRNewswire/ -- In light of the ongoing…
Acronis Appoints Terry Christie as General Manager for ANZ to Lead Regional Operations and Boost Platform Adoption
SYDNEY, June 12, 2025 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data…
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic…
MiningCoop’s latest cloud mining solution for Bitcoin and Dogecoin: Use AI cloud miners to earn passive income safely and efficiently
London, UK, June 07, 2025 (GLOBE NEWSWIRE) -- Amid growing global economic…
ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy
VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing…
The Billion-Dollar Heist and What It Means for Crypto Security: Bybit’s Security Overhaul After Hack
DUBAI, UAE, June 4, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
Aviva and FNZ unveil latest innovations to enhance adviser experience
Aviva platform continues development of innovative technology to support advisers.The latest innovation,…
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33…